Ipratropium & Anticholinergic Bronchodilators

When a COPD patient can't tolerate albuterol's tachycardia, ipratropium offers bronchodilation through an entirely different receptor system — but its slower onset changes how you use it. Know why that matters.

Ipratropium bromide (Atrovent) is a short-acting anticholinergic (muscarinic antagonist) bronchodilator. It works by blocking acetylcholine at M3 muscarinic receptors in bronchial smooth muscle, preventing the parasympathetic-driven bronchoconstriction and mucus hypersecretion that dominate COPD pathophysiology. This is fundamentally different from albuterol, which activates beta-2 receptors to relax smooth muscle. Ipratropium's onset is slower (15–30 minutes vs albuterol's 5–15 minutes), making it unsuitable as a sole first-line rescue inhaler in acute asthma. Peak effect occurs at 1–2 hours, and duration is 4–6 hours. Its primary indication is maintenance and acute management of COPD — not asthma as monotherapy. In the emergency setting, nebulized ipratropium is often combined with albuterol (DuoNeb/Combivent) for synergistic bronchodilation through dual receptor pathways. Because it acts locally with minimal systemic absorption, cardiac side effects are far fewer than beta-agonists, making it preferred in clients with coexisting cardiac disease.

Key Distinctions

Don't confuse ipratropium (short-acting anticholinergic, SAMA) with tiotropium (long-acting, LAMA — covered in the long-acting bronchodilators atom). Students commonly mistake ipratropium for a first-choice asthma rescue inhaler — it is not; albuterol remains first-line for acute bronchospasm. Ipratropium blocks parasympathetic bronchoconstriction (cholinergic), while albuterol stimulates sympathetic bronchodilation (adrenergic) — opposite sides of the autonomic nervous system.

Clinical Pearl

Think 'I-pratropium dries I-t up' — it blocks acetylcholine, so it dries secretions and opens airways. Dry mouth is expected, not alarming. Watch for other anticholinergic effects: urinary retention, constipation, blurred vision. It is contraindicated in narrow-angle glaucoma.